首页> 美国卫生研究院文献>BMC Cancer >Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

【2h】

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

机译：在常规临床实践中使用培美曲塞二线治疗III / IV期非小细胞肺癌（NSCLC）：评估表现状态和与健康相关的生活质量

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSecond-line treatment of advanced non-small-cell lung cancer (NSCLC) improves overall survival. There is a lack of data regarding the impact on patients' overall health condition. This prospective, non-interventional study evaluated performance status (PS) and health-related quality of life (HR-QoL) during second-line pemetrexed treatment in routine clinical practice.

机译：背景二线治疗晚期非小细胞肺癌（NSCLC）可提高整体生存率。缺乏有关对患者总体健康状况影响的数据。这项前瞻性，非干预性研究评估了常规临床实践中二线培美曲塞治疗期间的表现状态（PS）和健康相关的生活质量（HR-QoL）。

著录项

期刊名称 BMC Cancer
作者
Wolfgang Schuette; Hans Tesch; Hartwig Büttner; Thomas Krause; Victoria Soldatenkova; Clemens Stoffregen;
展开▼
作者单位

展开▼
年(卷),期 2012(12),-1
年度 2012
页码 14
总页数 12
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: Results by performance status, EGFR mutation, histology and response to previous induction [J] . Tan Pui San, Lopes Gilberto, Acharyya Sanchalika, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015 ,第16期

机译：一线诱导化疗后表现良好状态仍未进展的IIIb / IV期非小细胞肺癌（NSCLC）患者维持治疗的贝叶斯网络荟萃比较：按表现状态，EGFR突变，组织学和对既往反应的结果感应
2. Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer [J] . Spigel David R., Patel Jyoti D., Reynolds Craig H., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2015 ,第2期

机译：生活质量分析来自于培美曲塞-卡铂-贝伐单抗，维持培美曲塞-贝伐单抗与紫杉醇-卡铂-贝伐单抗再继之维持贝伐单抗的培美曲塞-卡铂-贝伐单抗的随机，开放标签，III期PointBreak研究，分析了IIIB或IV期非鳞状非-S患者细胞肺癌
3. 9034 Medical treatment choices of over 1000 Italian patients affected by stage IIIB-IV NSCLC in routine clinical practice: results from the observational ''SUN'' (Survey on the lUng cancer maNagement) study on behalf of SUN study Group [J] . L.Crinò, A.Ardizzoni, A.Caprioli, European Journal of Cancer Supplements . 2009 ,第2期

机译：在常规临床实践中，超过1000例受IIIB-IV期NSCLC影响的意大利患者的9034种医疗选择：代表SUN研究组的观察性“ SUN”（癌症管理调查）结果
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Pre-Treatment Radiomics Models for Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC) [D] . Shaffer, Nathan Allen. 2021

机译：早期非小细胞肺癌临床结果的预处理辐射瘤模型（NSCLC）
6. Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment [O] . Sheng-Bin Shi, Rong-Hang Hu, Jie-Lin Qi, -1

机译：厄洛替尼治疗失败后用培美曲塞加奥沙利铂治疗IIIb / IV期非小细胞肺癌
7. Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life [O] . Wolfgang Schuette, Hans Tesch, Hartwig Büttner, 2012

机译：在常规临床实践中使用培美曲塞二线治疗III / IV期非小细胞肺癌（NSCLC）：评估表现状态和与健康相关的生活质量

Second-line Treatment of Stage III/IV Non-Small-Cell Lung Cancer (NSCLC) with pemetrexed in routine clinical practice: Evaluation of performance status and health-related quality of life

摘要

著录项

相似文献

相关主题

期刊订阅